Hinge Health, Inc.
HNGE
$62.98
+7.36%
Related headlines
HNGE price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hinge Health, Inc.'s 12-month outlook, with a consensus price target around $81.87 and implied upside of +30.0% versus the current price.
Average Target
$81.87
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$50 - $82
Analyst target range
HNGE Technical Analysis
Beta
—
—
Max Drawdown
-48.5%
Largest decline past year
52-Week Range
$30-$64
Price range past year
Annual Return
+57.4%
Cumulative gain past year
| Period | HNGE Return | S&P 500 |
|---|---|---|
| 1m | +26.6% | +4.6% |
| 3m | +36.5% | +12.6% |
| 6m | +25.9% | +10.4% |
| 1y | +57.4% | +27.0% |
| ytd | +38.2% | +11.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is HNGE Overvalued?
PE
-7.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-6.5x
Enterprise Value Multiple